If breast cancer is discovered at an early stage, this significantly improves the chances of treatment. With Lunit INSIGHT DBT, Hollmann Medical offers practitioners an AI-controlled tool that supports medical work.
Lunit AI mammography AI software analyzes tissue during breast screening and automatically generates a quantitative density score. It also detects even the smallest deviations that cannot be seen with the naked eye.
Diagnostic accuracy even with dense breast tissue
Quantification of malignancy for suspicious lesions
Highlight lesions with grayscale outline or colored heatmaps
User-customizable graphics and evaluations
Proven quality, best results in practical use
Lunit is one of the leading providers of medical AI based in South Korea. The company has been focussing on the possibilities of AI in a medical context for over a decade. With its award-winning software, Lunit now supports the diagnostic work of renowned doctors and medical institutions worldwide. Hollmann Medical is a partner of Lunit in Germany.
Doctors analyse X-rays and CT scans to identify any anomalies. However, some of these cannot be identified with the human eye. In such cases, the use of Lunit INSIGHT DBT is a decisive advantage. The leading MMG AI has been trained on over 180,000 mammography images and recognises breast cancer with an accuracy of around 96%. The Lunit AI solution for mammography localises and flags suspicious soft tissue lesions and calcifications.
Suspicious lesions can be visualised as a 3D slice. An abnormality score is used to assess the probability of malignancy of each lesion.
The average survival rate for breast cancer depends on the stage of the disease. Supportive AI is useful for maximising diagnostic accuracy.
It offers:
